While it was shown that normally IRF8 binds to ASAH1’s promoter and represses ASAH1 transcription, in CML cells, IRF8 levels are markedly low allowing for ASAH1 expression. This evidence concerns the gene IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive.